Results 91 to 100 of about 6,952 (109)

Cancer therapy and reproductive impact. [PDF]

Int J Gynaecol Obstet
Feldberg D, Purandare N.
europepmc   +1 more source

3'-<i>O</i>-β-Glucosylation of nucleoside analogues using a promiscuous bacterial glycosyltransferase. [PDF]

RSC Chem Biol
Dolan JP, Keenan T, Cheallaigh AN, Fascione MA, Miller GJ.   +4 more
europepmc   +1 more source

Renal involvement in solid cancers: epidemiological, clinical and histological characteristics study of 154 onconephrology patients. [PDF]

BMC Nephrol
Gueutin V, Cardineau A, Mathian A, Lanot A, Comoz F, Brocheriou I, Izzedine H.   +6 more
europepmc   +1 more source

An analysis of the trends in the usage of Pharmaceutical Benefits Scheme-subsidised cancer drugs in Australia from 2012 to 2022. [PDF]

J Cancer Res Clin Oncol
Lee J, Panagiotelis A, Cairns R, Wheate NJ.   +3 more
europepmc   +1 more source

Characterization of the Antiproliferative and Antimetastatic Properties of <i>Centrapalus pauciflorus</i> Meroterpenoid Centrapalus Coumarin F. [PDF]

Int J Mol Sci
Ali H, Rasool S, Saidu MB, Germán P, Szebeni GJ, Szabó E, Rédei D, Hohmann J, Zupkó I.   +8 more
europepmc   +1 more source

Survival for the fittest: guadecitabine in rel/ref AML. [PDF]

Blood Adv
Sheehy J, Lane SW.
europepmc   +1 more source

SGLT2 Inhibitors in Cancer Patients: A Comprehensive Review of Clinical, Biochemical, and Therapeutic Implications in Cardio-Oncology. [PDF]

Int J Mol Sci
Greco A, Canale ML, Quagliariello V, Oliva S, Tedeschi A, Inno A, De Biasio M, Bisceglia I, Tarantini L, Maurea N, Navazio A, Corda M, Iacovoni A, Colivicchi F, Grimaldi M, Oliva F.   +15 more
europepmc   +1 more source

DNA repair and the contribution to chemotherapy resistance. [PDF]

Genome Med
Nesic K, Parker P, Swisher EM, Krais JJ.
europepmc   +1 more source

Prediction of High-Dose Methotrexate Blood Concentration in Osteosarcoma Patients Using Machine Learning. [PDF]

Drug Des Devel Ther
Zhao J, Dai S, He J, Liu N, Zhang B, Li S.   +5 more
europepmc   +1 more source

Are Turkish pharmaceutical pricing strategies an access barrier to oncology medicines for Türkiye? [PDF]

Front Pharmacol
Vural EH, Kaskati T, Vural İM, Özalp MA, Gümüşel B.   +4 more
europepmc   +1 more source